Tang-Ping-San Decoction Remodel Intestinal Flora and Barrier to Ameliorate Type 2 Diabetes Mellitus in Rodent Model
Wen Yin,Si-Qi Zhang,Wen-Lin Pang,Xiao-Jiao Chen,Jing Wen,Jiong Hou,Cui Wang,Li-Yun Song,Zhen-Ming Qiu,Peng-Tao Liang,Jia-Li Yuan,Zhong-Shan Yang,Yao Bian
DOI: https://doi.org/10.2147/DMSO.S375572
2022-08-21
Abstract:Wen Yin, &ast Si-Qi Zhang, &ast Wen-Lin Pang, &ast Xiao-Jiao Chen, Jing Wen, Jiong Hou, Cui Wang, Li-Yun Song, Zhen-Ming Qiu, Peng-Tao Liang, Jia-Li Yuan, Zhong-Shan Yang, Yao Bian Yunnan Provincial Key Laboratory of Molecular Biology for Sinomedicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhong-Shan Yang; Yao Bian, Yunnan University of Chinese Medicine, Kunming, Yunnan, People's Republic of China, Tel +86-871-65919932, Email yangzhongsh; Purpose: Type 2 diabetes mellitus (T2DM) is a complex genetic disease associated with genetic and environmental factors. Previous studies have shown that changes in the gut microbiota may affect the development of host metabolic diseases and promote the progression of T2DM. Tang-ping-san (TPS) decoction can effectively treat T2DM. However, its specific mechanisms must be evaluated. Patients and Methods: In the present study, we established an animal model of T2DM using a high‐fat diet (HFD) with intraperitoneal injection streptozotocin injection. Results: The therapeutic effect of TPS decoction on T2DM in mice was initially evaluated. TPS decoction was found to improve hyperglycemia, hyperlipidemia, insulin resistance, and pathological liver, pancreatic, and colon changes. Moreover, it reduced the pro-inflammatory cytokine levels. Based on 16SrRNA sequencing, TPS decoction reduced the Firmicutes/Bacteroidetes ratio at the phylum level. At the genus level, it increased the relative abundances of Akkermansia, Muribaculaceae , and the Eubacterium coprostanoligenes group and decreased the relative abundance of Fusobacterium, Escherichia coli, Dubosiella , and Helicobacter . Conclusion: TPS decoction improves T2DM and liver function and reduces the risk of hyperglycemia, hyperlipidemia, insulin resistance, pathological organ changes, and inflammatory reactions. The mechanism of TPS decoction in T2DM can be correlated with the reversal of gut microbiota dysfunction and repair of the intestinal mucosal barrier. Keywords: type 2 diabetes mellitus, tang-ping-san decoction, gut microbiota, glycolipid metabolism, insulin resistance Type 2 diabetes (T2DM) is a complex endocrine disease associated with several environmental and genetic factors. The final endpoint of this condition is pancreatic islet failure or insufficient insulin (INS) action causing high blood glucose levels. 1 T2DM poses global burdens and the number of patients with T2DM can reach up to 642 million in 2040. 2 Nevertheless, the causes of T2DM have not been completely elucidated. The lack of effective treatments is a significant challenge worldwide. As the second genome in humans, the gut microbiota (GM) has a close relationship with immunity, intestinal inflammation, and mental and metabolic diseases. 3–5 Previous studies have shown that GM is involved in glucose metabolism disorders and insulin resistance (IR). Patients with T2DM can develop GM imbalance. 6 The human intestine is a complex micro-ecosystem. Several bacteria participate in host metabolism. Under physiological conditions, the GM maintains glycolipid metabolism stability by digesting and absorbing food and by generating metabolites. 7 Unhealthy eating habits can disrupt intestinal bacteria, which alters host metabolism leading to T2DM. Compared with healthy people, patients with T2DM had a lower abundance of Lactobacillus and Akkermansia in the gut and a higher abundance of harmful bacteria such as Enterobacteriaceae . 8 Abnormal metabolite levels secondary to intestinal flora disorders are associated with inflammation, IR, and glucose and lipid metabolism disorders. 9 Probiotics such as Roseburia, Bacteroides, Akkermansia , and Lactobacillus can help treat glucose metabolism disorders and restore INS sensitivity. 10 Metformin alters the abundance of Bacteroidetes, Escherichia , and other bacteria to maintain the intestinal barrier and promote the production of short-chain fatty acids (SCFAs). These mechanisms alter bile acid metabolism and decrease blood glucose levels. 11 High-fat and high-sugar diets change the GM and cause intestinal inflammation by destroying tight junctions, increasing intestinal tract permeability, 12,13 producing lipopolysaccharide (LPS), altering the bacterial composition, and allowing the entry of intestinal flora into the circulation. These phenomena result in chronic metabolic inflammation, IR, and T2DM exacerbation. 14 Elevated serum LPS levels are referred to as metabolic -Abstract Truncated-